Home Products Antibodies Biochemicals Research Areas
Service & Support Custom Services Support Promotion About Us
Sign In Sign Up

APOBEC3G Rabbit pAb  (Cat.#:AYP19267)

A
小A 扫码咨询
Host: RabbitClonality: PolyclonalReactivity: Human,Mouse,RatWBIHCIF/ICC
货号 AYP19267
靶点/基因 APOBEC3G
宿主 Rabbit
克隆性 Polyclonal
反应种属 Human, Mouse, Rat
应用 WB, IHC, IF/ICC

Cat.#:AYP19267

SizePrice
50ul ¥1150.00 AddToCart
100ul ¥2100.00 AddToCart
  • Information

  • 应用指南

  • Related products

  • Immunogen

  • Target data

  • 资料与支持

  • Protocols

  • FAQs

Reactivity Human,Mouse,Rat
Host Rabbit
Clonality Polyclonal
同种型 IgG
Application WBIHCIF/ICC
Dilution WB: 1:500 - 1:1000
IHC: 1:50 - 1:200
IF/ICC: 1:50 - 1:200
Predicted MW 9kDa/46kDa
Observed MW 45KDa
Format Liquid
Storage Store at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.01% thiomersal,50% glycerol,pH7.3.
Conjugate Unconjugated
Positive PC-3
Subcellular Cytoplasm,Nucleus,P-body
Purification Affinity purification

应用与推荐条件

快速判断怎么用

以下条件基于推荐浓度、验证图说明与通用实验要求整理,可作为预实验起点;不同样本和检测体系建议做梯度优化。

WB WB 推荐条件
推荐稀释 1:500 - 1:1000
建议样本/阳性对照 PC-3
关键条件 建议使用新鲜裂解样本,按推荐稀释比例孵育一抗,并关注理论/实测分子量
预期结果 预期信号/条带约 45KDa
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IHC IHC 推荐条件
推荐稀释 1:50 - 1:200
建议样本/阳性对照 PC-3
关键条件 石蜡切片建议优化抗原修复液 pH、修复时间和一抗孵育条件
预期结果 预期定位:Cytoplasm,Nucleus,P-body
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IF/ICC IF/ICC 推荐条件
推荐稀释 1:50 - 1:200
建议样本/阳性对照 PC-3
关键条件 建议优化固定、通透和封闭条件,并设置二抗空白对照
预期结果 预期荧光定位:Cytoplasm,Nucleus,P-body
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照

Related products

More associated products >>

Immunogen

Immunogen A synthetic peptide corresponding to a sequence within amino acids 200-300 of human APOBEC3G (NP_068594.1).
Sequence
查看序列
PTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVLLNQRRGFLCNQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFIS

Target data

Background This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. The protein encoded by this gene catalyzes site-specific deamination of both RNA and single-stranded DNA. The encoded protein has been found to be a specific inhibitor of human immunodeficiency virus-1 (HIV-1) infectivity.
Gene ID 60489
Gene name APOBEC3G
Swiss Q9HC16
Synonym APOBEC3G,A3G,ARCD,ARP-9,ARP9,CEM-15,CEM15,MDS019,bK150C2.7,dJ494G10.1,APOBEC3G Rabbit pAb,APOBEC-related cytidine deaminase,APOBEC-related protein 9,Deoxycytidine deaminase
Expression Expressed in spleen, testes, ovary and peripheral blood leukocytes and CD4+ lymphocytes. Also expressed in non-permissive peripheral blood mononuclear cells, and several tumor cell lines; no expression detected in permissive lymphoid and non-lymphoid cell lines. Exists only in the LMM form in peripheral blood-derived resting CD4 T-cells and monocytes, both of which are refractory to HIV-1 infection. LMM is converted to a HMM complex when resting CD4 T-cells are activated or when monocytes are induced to differentiate into macrophages. This change correlates with increased susceptibility of these cells to HIV-1 infection.
Functions DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits potent antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double-stranded RNA. Exhibits antiviral activity also against simian immunodeficiency viruses (SIVs), hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV). May inhibit the mobility of LTR and non-LTR retrotransposons.

资料与技术支持

验证数据

1 张验证图

页面顶部轮播可查看应用验证图,覆盖 WB / IHC / IF/ICC。

文献引用

暂无公开文献关联,欢迎联系技术支持获取更多应用案例。

咨询案例
客户评价

暂无客户评价,使用后可提交评价与实验图片。

提交反馈
技术支持

可协助确认应用、样本、稀释比例、阳性/阴性对照和实验条件。

进入支持中心
需要确认应用条件?

请提供货号 AYP19267、实验应用、样本类型和检测体系,技术支持可协助确认稀释比例、阳性/阴性对照和 COA/批次资料。

FAQs

当前页面标注应用包括 WB, IHC, IF/ICC,建议结合页面验证图和推荐稀释比例进行预实验优化。
可通过页面询价/留言入口提交货号和批号,技术支持会协助提供对应批次资料。
页面推荐条件可作为起始浓度,不同样本、固定方式和检测体系可能需要梯度优化。

Protocols

Protocols
AYP19267